Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026

Same author

Rethinking health technology assessment in robotic surgery: an EFISDS-TROGSS position paper. Official position paper of the European Federation - International Society for Digestive Surgery (EFISDS) and The Robotic Global Surgical Society (TROGSS).

Journal of robotic surgery·2026

Same author

Current-controlled electrical stimulation regulates growth, redox adaptation, and lipid accumulation in Chlorella vulgaris.

Bioresource technology·2026

Same author

Short-term outcomes of robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal cancer: a systematic review and meta-analysis.

Journal of robotic surgery·2026

Same author

Cardiovascular Disease and Dyslipidemia in Pediatric Type 1 Diabetes.

Current atherosclerosis reports·2026

Same author

The Swiss army knife illusion: Preserving the human dimension in the age of AI.

Current problems in surgery·2026

Search research articles

Related Experiment Video

Updated: Aug 30, 2025

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

Current Cannabidiol Safety: A Review.

Chander Singh¹, Komal Rao¹, Nikita Yadav¹

¹School of Medical & Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India.

Current Drug Safety

|September 3, 2022

Summary

Cannabidiol (CBD), a non-psychoactive cannabis compound, shows promise for treating inflammation and other conditions like epilepsy and anxiety. While generally safe, potential side effects warrant consideration in its therapeutic applications.

Keywords:

CBD Cannabidiol D-9-tetrahydrocannabinol (9-THC)cannabis marijuana safety

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Administration of Δ⁹-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

Related Experiment Videos

Last Updated: Aug 30, 2025

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Administration of Δ⁹-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

Area of Science:

Pharmacology and Therapeutics
Natural Product Chemistry

Background:

Cannabis, containing psychoactive D-9-tetrahydrocannabinol (9-THC) and non-psychoactive cannabidiol (CBD), is widely used globally.
Cannabidiol (CBD) is explored for its anti-inflammatory properties and therapeutic potential.
This review focuses on CBD's anti-inflammatory applications and safety profile.

Approach:

Literature review encompassing Google Scholar, PubMed, and Google Patents.
Inclusion of numerous clinical investigations on cannabis and its compounds.
Analysis of scientific literature to evaluate CBD's efficacy and safety.

Key Points:

Cannabis compounds, including CBD, are investigated for treating various conditions such as pain, epilepsy, cancer, and anxiety.
Cannabidiol (CBD) has demonstrated efficacy in clinical trials for epilepsy, anxiety, and acne, and possesses pain relief and anti-inflammatory properties.
While cannabis use has potential side effects like infertility and liver damage, CBD is generally considered to have a favorable safety profile.

Conclusions:

Cannabidiol (CBD) is a non-psychoactive cannabinoid with significant therapeutic potential, particularly for inflammatory conditions.
CBD has been validated in clinical trials for treating epilepsy (e.g., Epidiolex), anxiety, and acne.
Further research into CBD's applications and safety is ongoing, with potential for broader medical use.